Cargando…

Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti‐IL2 Receptor Monoclonal Antibodies?

Induction therapy with antilymphocyte biological agents is widely used after kidney transplantation, most commonly T lymphocyte‐depleting rabbit‐derived antithymocyte globulin (rATG) or an IL‐2 receptor antagonist (IL2RA). Early randomized trials showed that rATG or IL2RA induction reduces early acu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hellemans, R., Bosmans, J.‐L., Abramowicz, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215533/ https://www.ncbi.nlm.nih.gov/pubmed/27223882 http://dx.doi.org/10.1111/ajt.13884

Ejemplares similares

Hyperkalemia: Major but still understudied complication among heart transplant recipients
por: Singh, Jagmeet, et al.
Publicado: (2021)

Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do
por: Sanchez-Torrijos, Yolanda, et al.
Publicado: (2017)

Liver transplantation for hepatocellular carcinoma: Where do we stand?
por: Santopaolo, Francesco, et al.
Publicado: (2019)

Nanotherapeutics in transplantation: How do we get to clinical implementation?
por: Plumblee, Leah, et al.
Publicado: (2022)

Stem cell therapy for insulin-dependent diabetes: Are we still on the road?
por: Yang, Lu, et al.
Publicado: (2022)

Introduction of everolimus in kidney transplant recipients at a late posttransplant stage
por: Uchida, Junji, et al.
Publicado: (2018)

Sodium-glucose cotransporter-2 inhibitor use in kidney transplant recipients
por: Ramakrishnan, Pavithra, et al.
Publicado: (2023)

Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2021)

Do we still need supertrees?
por: Haeseler, Arndt von
Publicado: (2012)

Renal transplant recipient seizure practical management
por: Sawhney, Harpreet, et al.
Publicado: (2020)

Addictive behaviors in liver transplant recipients: The real problem?
por: Donnadieu-Rigole, Hélène, et al.
Publicado: (2017)

More than skin deep? Potential nicotinamide treatment applications in chronic kidney transplant recipients
por: Bostom, Andrew G, et al.
Publicado: (2016)

Does steroid-free immunosuppression improve the outcome in kidney transplant recipients compared to conventional protocols?
por: Aref, Ahmed, et al.
Publicado: (2021)

The state of the art: immune-mediated mechanisms of monoclonal antibodies in cancer therapy
por: Griggs, J, et al.
Publicado: (2009)

Immunity to SARS-CoV-2: What Do We Know and Should We Be Testing for It?
por: Misra, Anisha, et al.
Publicado: (2022)

Mass Spectrometry Approaches for Identification and Quantitation of Therapeutic Monoclonal Antibodies in the Clinical Laboratory
por: Ladwig, Paula M., et al.
Publicado: (2017)

Clinical application of SARS-CoV-2 antibody detection and monoclonal antibody therapies against COVID-19
por: Sun, Jin, et al.
Publicado: (2023)

Clinical and pathophysiological understanding of the hepatorenal syndrome: Still wrong or still not exactly right?
por: Wilde, Benjamin, et al.
Publicado: (2023)

Imlifidase for the treatment of anti‐HLA antibody‐mediated processes in kidney transplantation
por: Huang, Edmund, et al.
Publicado: (2021)

Renal manifestations of hepatitis E among immunocompetent and solid organ transplant recipients
por: Kovvuru, Karthik, et al.
Publicado: (2022)

Thrombocytopenia after liver transplantation: Should we care?
por: Takahashi, Kazuhiro, et al.
Publicado: (2018)

Assessing the prognosis of cirrhotic patients in the intensive care unit: What we know and what we need to know better
por: da Silveira, Fernando, et al.
Publicado: (2021)

Defining the Pseudomonas Genus: Where Do We Draw the Line with Azotobacter?
por: Özen, Asli I., et al.
Publicado: (2011)

Viscoelastic tests in liver disease: where do we stand now?
por: Buliarca, Alina, et al.
Publicado: (2021)

Hepatitis C virus micro-elimination: Where do we stand?
por: Mangia, Alessandra, et al.
Publicado: (2021)

COVID-19 and the liver: Are footprints still there?
por: Gupta, Tarana, et al.
Publicado: (2023)

Predicting systemic spread in early colorectal cancer: Can we do better?
por: Brockmoeller, Scarlet Fiona, et al.
Publicado: (2019)

Role of endoscopic ultrasound in liver disease: Where do we stand in 2017?
por: Saraireh, Hamzeh A, et al.
Publicado: (2017)

SARS-CoV-2 breakthrough infections in vaccinated kidney transplant recipients: an issue of concern
por: Wijtvliet, Veerle, et al.
Publicado: (2021)

True effect of monoclonal antibody for COVID-19 in kidney transplant recipients
por: Khatri, Akshay, et al.
Publicado: (2022)

Updates on antibody-mediated rejection in intestinal transplantation
por: Wu, Guo-Sheng
Publicado: (2016)

Treatment options for small cell lung cancer – do we have more choice?
por: Puglisi, M, et al.
Publicado: (2010)

Magnetic resonance enterography in Crohn’s disease: How we do it and common imaging findings
por: Mantarro, Annalisa, et al.
Publicado: (2017)

Image guided percutaneous gastrostomy catheter placement: How we do it safely and efficiently
por: Partovi, Sasan, et al.
Publicado: (2020)

Advanced imaging and artificial intelligence for Barrett's esophagus: What we should and soon will do
por: Spadaccini, Marco, et al.
Publicado: (2022)

Association between acute pancreatitis and COVID-19 infection: What do we know?
por: Jabłońska, Beata, et al.
Publicado: (2021)

Yeast osmoregulation – glycerol still in pole position
por: Blomberg, Anders
Publicado: (2022)

Why do we still need participatory technology assessment?
por: Hennen, Leonhard
Publicado: (2012)

Do we still need renal biopsy in lupus nephritis?
por: Haładyj, Ewa, et al.
Publicado: (2016)

Screening and surveillance methods for dysplasia in inflammatory bowel disease patients: Where do we stand?
por: Galanopoulos, Michail, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fh3i8hcte5dov9rnnbb8qih4di